Professional Documents
Culture Documents
The Daily
August 10, 2022
The Daily
DOMESTIC INDICES Indian markets could open flat to mildly lower, in line
with mostly lower Asian markets today and lower US
CLOSE POINTS % CHANGE
markets on Tuesday..…
SENSEX 58853 465 0.80
NIFTY 17525 128 0.73 The S&P 500 and Nasdaq Composite indexes failed to hold
onto earlier gains on Monday, while the Dow Jones
MIDCAP 24556 77 0.31
Industrial Average finished slightly higher, as investors
SMALL CAP 27682 77 0.28 await this week’s consumer-price index report for July,
which could lead to expectations for further Fed
SECTORAL INDICES tightening. Stocks failed to hold onto gains, with a gloomy
forecast from Nvidia Corp. weighing on technology shares
CLOSE POINTS % CHANGE and traders awaiting inflation data for clues on the pace of
CG 30291 593 2.00 Federal Reserve rate hikes.
POWER 4777 90 1.92
METAL 18588 234 1.27 U.S. consumers' expectations for where inflation will be in
a year and three years dropped sharply in July, a New York
AUTO 29674 309 1.05
Federal Reserve survey showed on Monday, a win for
Fi nance 8203 71 0.87
policy makers.
BANKEX 43852 301 0.69
CD 40341 230 0.57 U.S. stocks finished lower on Tuesday as anxieties about
Hea lthcare 23254 69 0.30 looming inflation data and a selloff in semiconductor
TECK 13867 28 0.20 stocks drove the S&P 500 to its fourth straight losing
session. Stocks fell as warnings from semiconductor
REALTY 3490 4 0.10
stalwarts Nvidia Corp and Micron Technology Inc. rattled
IT 30393 7 0.02 chip stocks even as President Joseph Biden signed the
OIL & GAS 19330 -6 -0.03 bipartisan Chips and Science Act into law. Meanwhile,
anxieties ahead of inflation reports due out Wednesday
and Thursday helped to put the market’s recent rally on
BSE 200 GAINERS/LOSERS
pause.
GAINERS % LOSERS %
JSWENERGY 9.06 HINDPETRO -4.65 Economists polled by FactSet expect headline CPI to slow
to 8.7% in July (vs 9.1% in June), but a hotter-than-
HAL 8.09 YESBANK -3.90
expected reading on either the headline number, or the
PAYTM 6.46 ALKEM -3.43 core number — which strips out volatile food and energy
SIEMENS 4.66 BPCL -3.14 prices — could rattle markets.
ADANITRANS 4.39 MFSL -3.07
Stocks dipped in Asia on Wednesday following a Wall
Street r etreat and caution ahead of US inflation data that
ADVANCE/DECLINES will shape investor expectations for further Federal
Reserve interest-rate hikes. Chinese shares wavered as
BSE % traders evaluated slower-than-anticipated consumer and
ADVANCES 1942 53 factory inflation in the world’s second-largest economy. In
DECLINES 1556 42 China, consumer price inflation accelerated in July to 2.7%,
the highest level in two years, but missed economists’
UNCHANGED 172 5
expectations. The producer price index climbed 4.2%,
below the median forecast and down from June.
INSTITUTIONAL ACTIVITY
Nifty picked up pace after a dull opening on Aug 08 to
Rs Cr 05-08-2022 08-08-2022 AUG TOTAL close near the intra day high formed at 1335 Hrs. At close,
FII 1606 1450 9488 Nifty was up 0.73% or 127.6 points at 17525.1.
DII -496 -141 -1907
2
The Daily
3
The Daily
GAIL to double share capital; add specialty chemicals, clean energy to business
GAIL (India) Ltd wants to double its share capital as well as add specialty chemicals and clean energy to its line of
business as it looks to diversify business beyond natural gas transmission and distribution. GAIL has sought shareholder
approval to increase the authorised share capital of the company to Rs 10,000 crore from the current Rs 5,000 crore to
help raise finance for its expansion plans over the next 3-4 years.
Reported numbers
• Consolidated revenue gr ew by 22.2% YoY to Rs 32,804 crore vs expectation of Rs 32,280 crore in Q1FY23, driven by
rapidly increasing demand for data, connectivity related solutions, tariff hike benefit and CPaaS (Communication
Platform as a Service).
• EBITDA was up by 27.3% YoY to Rs 16,529 crore.
• EBITDA margin ramped up by 210bps YoY to 50.4% in Q1FY23.
• Net Profit stood at Rs 2,469 crore in Q1FY23, supported by healthy operating profit vs. expectation of Rs 1400 crore.
Net profit was at Rs 941 crore in Q1FY22.
•PAT margin stood at 7.5% in Q1FY23 vs. 3.5% in Q1FY22.
Subcribers
• As of June 30, 2022, the company’s overall customer base stands at ~497 million across 16 countries with India having
~362 mn customers and Africa stands at 131.6 mn.
•4G customers up by 20.8 Mn YoY & 4.5 Mn QoQ, 63% of overall customer base,
• Homes business reported continued momentum, net additions of 1.4 Mn in Q1FY23 YoY.
• Mobile data consumption up by 16.6% YoY, consumption per mobile data customer at 19.5 GB per
Month in Q1FY23 vs. 18.8 GB per month in Q4FY22
•Digital TV customer base was at 17.4 Mn in Q1FY23 vs. 17.6 Mn in Q4FY22.
• Airtel Payments Bank continued to witness accelerated adoption leading to increase in monthly transacting users by
65% YoY.
ARPU
Average revenue per user (ARPU) continued to be best in industry as Q1FY23, ARPU came in at Rs 183 vs. Rs 178 in
Q4FY22, Rs 163 in Q3FY22, Rs 153 in Q2FY22 and Rs 146 in Q1FY22 on a comparable basis.
4
The Daily
Capex
• Consolidated capex spend in the quarter was Rs 6,398 crore out of which capex in India stood at Rs 5,288 crore while
Africa contributed the capex of Rs 1,088 crore in the quarter.
Key Development
•Airtel procured 19,867.8 MHz spectrum for Rs 43,040 crore in the recently concluded 5G spectrum.
Consolidated net revenue gr ew by almost two and half fold than same quarter previous year. Reported net revenue at
Rs 3194 crore in Q1FY23.
EBITDA was up by 62% YoY to Rs 618 crore in Q1FY23 and EBITDA margin slipped to 19.3% in Q1FY23 vs. 30.3% in in
Q1FY22. Net Profit increased by 73% YoY at Rs 481 crore in Q1FY23, supported by strong revenue growth. PAT margin
was at 15.1% in Q1FY23 vs. 22.1% in Q1FY22.
Overall sales volume was at 717.84 million standard cubic meters (mscm) in Q1FY23 vs. 483.77 mscm in Q1FY22. It
registered an average daily sale of 7.89 million standard cubic meters in the quarter as compared to 5.32 million
standard cubic meters per day sales in the year-ago period.
CNG registered sales volume at 539.8 million standard cubic meters in Q1FY23 vs. 331.78 million standard cubic meters
in Q1FY22, 63% YoY growth. PNG overall sales volume growth of 17% in the quarter on YoY basis at 178.04 million
standard cubic meters.
CNG registered sales (value) growth of 177% YoY and PNG 107% in the the quarter on YoY basis. CNG and PNG revenue
in value term contributed 74% and 26% respectively in Q1FY23.
The company’s EPS in Q1FY23 was at Rs 6.9, and Rs 6.2 in Q4FY22. At a CMP, stock trades at 18x FY24E EPS.
eClerx consolidated revenue gr ew by 4.4% QoQ and 27.1% YoY at Rs 726 crore in Rupee terms. Constant currency (CC)
growth by 3.9% QoQ and 25.2% on YoY basis. Revenue in US$, 3% QoQ and to US$ 79.5.
EBIT margin degrew by 23% QoQ to Rs 119 crore and it was up by 1% on YoY basis, EBIT Margin stood at 19.2% QoQ in
Q1FY23, vs. 26% in Q4FY22 and 24.2% in Q1FY22. Net Profit declined by 16% QoQ to Rs 100 crore in Q1FY23 and it
increased by 8% YoY. PAT margin stood at 16.1% in Q1FY23 vs. 20% in Q4FY22, and 18.9% in Q1FY22.
On geography front, North America, Europe and Asia contributed 70%, 22% and 8% in Q1FY23, respectively vs. North
America, Europe and Asia contributed 69%, 23% and 8% in Q4FY22, respectively.
eClerx added six new clients in the the US$ 500K -1 mn category in the quarter, top 10 clients contributed 60% to the
revenue in Q1FY23. The total delivery headcount as of June 30, 2022 stands at 16,067 – an increase of 26.1% YoY
5
The Daily
Total Cash and Cash Equivalents of Rs 763 crore as on June 30, 2022 vs. Rs 681 crore as on March 31, 2022, equivalent
to Rs 230.5 per share Q1FY23 vs Rs 205.6 for Q4FY22. Earnings per share was at Rs 29.4 in Q1FY23, and Rs 35.2 in
Q4FY22. At a CMP of Rs 2306, stock is trading at at 15.5x FY24E EPS.
Gujarat Narmada Valley Fertilizers & Chemicals Ltd. (GNFC) – Q1FY23 Result update
Revenue for Q1FY23 at Rs. 2696 Cr, up 93.4 % YoY and down 2.7 % QoQ . Gross Margins for Q1FY23 at 56.86% (-520 bps
YoY, 235 bps QoQ). EBITDA for Q1FY23 at Rs 762 Cr, up 94% YoY and down 14% QoQ and EBITDA Margins for Q1FY23 at
28.26% (8 bps YoY, -370 bps QoQ)
Reported PAT for Q1FY23 at Rs. 571 Cr, up 136% YoY and down 11% QoQ. While all business segments have witnessed
positive results, the key driver of profitability is chemical realisation buoyancy. The Q1FY23 Operating Revenue at Rs
2,696 Cr is historical highest which is 68% higher than previous highest ever first quarter revenue r ecorded in Q1FY19.
Although as compared to Q4FY22 volumes and operating margins are slightly lower due to some operating disturbances
mainly in urea production apart from market related issues in chemicals like Aniline and Formic Acid. In product like
methanol due to skewed trends of natural gas vs. methanol, buying methanol offered better opportunity to save on
costs as against in-house production.
Capex Update:
Formic Acid: Brown field expansion project is completed with commercial production as well as plant stabilisation phase
is over. This is adding capacity by 6,800 MTPA. The project cost of Rs 53 Cr.
Concentrated Nitric Acid: During FY23, Concentrated Nitric Acid plant with a capacity of 50,000 MTPA. is expected to be
commissioned by Q4.
Renewal Power Capex: In addition to 10 MW Solar Power Plant operationalised during last FY, additional 4 MW Solar
Power Plant with capex size of Rs 26 Crs is expected to be commissioned during current FY23.
Capacity adding brownfield projects: Ammonia capacity enhancement project with additional capacity of 50,000 MTPA
Weak Nitric Acid project with a capacity by 2,00,000 MTPA and Ammonium Nitrate Melt project with capacity of
1,63,000 MTPA are on track. The total capex size of these projects is around Rs1,350 Crs.
Others: Capex proposals for further foray into Green Hydrogen, Green Ammonia, Polycarbonate and other chemicals are
at active evaluation stage. Estimated capex on account of these projects is around Rs 2,900 Cr
6
The Daily
The company is hopeful of maintaining the momentum keeping its continuous focus on improving operating margins
with its focus on value accretive capex while keeping a sharp focus on current product mix.
Pharmaceutical Formulation Intermediates (PFI) segment revenue grew 38% YoY at Rs 237cr, Active Pharmaceutical
Ingredients (API) revenue grew 5% YoY at Rs 234cr and Finished Dosage (FD) business increased 20.7% YoY at Rs 549cr.
During the quarter, the company filed 5 ANDAs, 2 US DMFs. R&D expenses stood at Rs 32cr or 3.1% of sales as against Rs
27cr or 3.2% of sales in Q1 FY22.
Granules derived 38% of revenue from Paracetamol, 25% from Metformin, 12.5% from Ibuprofen, and the balance from
others.
Board approved buyback of 62.5 lakh equity shares at Rs 400 per share. The total buyback size would be around Rs
250cr. It would be through tender offer route. Company has fixed record date as Aug 23, 2022 for the said buyback.
EPS for the quarter stood at Rs 5.1. Net debt stood at Rs 613cr as on Jun-2022. At CMP, the stock trades at 13x FY24E
EPS.
API revenue stood at Rs 51cr. Export formulations business (incl. subsidiaries) registered significant growth at Rs 737cr.
Domestic formulation revenue stood at Rs 88.5cr.
During the quarter, export sales of gRevlimid to US was a major contributor to revenue and profitability of the business.
Domestic formulations business remained steady. On the expense side, there was a one-time cost associated with
retirement schemes during the quarter and higher than usual R&D costs for product development.
Board declared Rs 3.5 per share as interim dividend. EPS for the quarter stood at Rs 17.5. At CMP, the stock trades at
16x FY23E EPS.
Domestic formulation revenue declined 7% YoY at Rs 200cr. Regulated market revenue grew 15% YoY at Rs 147.7cr.
Emerging Markets revenue gr ew 23% YoY at Rs 29.7cr. The growth in the domestic formulations business was muted
due to the Covid impact and de-growth in two segments, Respiratory and Anti-infectives (ATM & Karvol Plus).
7
The Daily
EPS for the quarter stood at Rs 4.2. At CMP, the stock trades at 17.5x FY24E EPS.
PBT before exceptional items grew 136% YoY at Rs 91.6cr. Net profit declined 7.5% YoY at Rs 37.2cr. Other Income
declined 35% YoY at Rs 6.55cr.
India revenue increased 35% YoY at Rs 3059cr. Mexico business grew 43% YoY at Rs 673cr.
Company achieved its highest ever sales in the quarter. There has been a healthy pickup in demand in both for
passenger and for commercial tyres, both in the replacement and original equipment markets (OEM). Raw material and
other input costs witnessed an on-going uptrend, thus impacting margin and profitability. Company has undertaken
multiple price revisions though not to the full extent and will pursue further opportunities.
Cavendish Industries Ltd. and JK Tornel, Mexico, subsidiaries of the company have also seen strong growth in the
quarter.
Earlier, the company said that it will reduce its long-term borrowings significantly over the next 3 years. Board had
approved PCR capacity expansion of Rs 530cr at Banmore tyre plant, MP.
EPS for the quarter stood at Rs 1.51. At CMP, the stock trades at 8.5x FY24E EPS.
Formulations business grew 19.5% on constant currency basis, driven by strong performance in LatAm within the overall
Emerging Markets region. API revenue was subdued owing to impact of a fire incident at Vizag plant in May 2022, as the
operations were hampered for a few days.
API business declined 2.5% YoY at Rs 88.8cr. Formulation business grew 8% YoY at Rs 244.8cr. India formulation business
registered 5% YoY at Rs 23.7cr.
Demand environment remains stable; input cost pressures and supply chain weaknesses continue to impact the
formulations business.
EPS stood at Rs 1.7 for FY22. Net debt stood at Rs 292cr as on Jun-2022. At CMP, the stock trades at 30x FY24E EPS.
Minda derived 83% of revenue from domestic market and 17% from International markets.
Switch segment revenue contribution stood at 29%, Lighting at 23%, Castings at 19%, Seating at 10%, Acoustics at 7%
and the balance from others.
Company had won orders worth Rs 513cr from EV segment in FY22 and orders of Rs 470cr in Q1 FY23.
8
The Daily
EPS for the quarter stood at Rs 2.42. At CMP, the stock trades at 29.5x FY24E EPS.
Company guides for 25% revenue growth for FY23. Company would implement 15% price hike across portfolio to
counter higher raw material costs.
On segment-wise performance, the company's transmission business revenue stood at Rs 10,702.98 crore in Q1FY23
rising by 5.90% yoy, while the consultancy and telecom business registered a revenue of Rs 235.39 crore and Rs 190.32
crore in Q1 of this fiscal with a growth of 50.61% and 60.18% year-on-year.
Consolidated revenue of the Gautam Adani-owned company remained flat on-year at Rs 4,638 crore from Rs 4,671 crore
in the year-ago quarter. Sequentially, the revenue was 20.6 percent higher than Rs 3,845 crore recorded in the previous
quarter.
The cargo business generated revenues of Rs 4,090 crore at a YoY growth of 18 percent (this does not include revenues
from Ganagavaram port) while the logistics business generated revenues of Rs 360 crore at a YoY growth of 34 percent.
During the quarter the company handled a total cargo volume of 91 MMT (million metric tonnes) at a YoY growth of 8
percent. This includes 9.09 MMT at Gangavaram port which witnessed a YoY growth of ~8 percent.
The por t business witnessed an 8 percent YoY growth in volumes which aided in an 18 percent YoY growth in its EBITDA
(earnings before interest, tax, depreciation and amortization) at Rs 2,885 crore while the EBITDA for its logistics business
jumped 56 percent on year to Rs 96 crore.
9
The Daily
For F.Y. 2022-2023, Company estimates capex of Rs 300 crores which includes Mill Lining Project, Grinding Media
Expansion Project and Hybrid Power Project Wind and Solar Power in addition to general capex. Order book as at 1st
July 2022: Rs. 700 Crores.
Japan's current account shifted to a deficit of JPY 132.4 billion in June 2022 from a surplus of JPY 739.6 billion in the
same month of the previous year and compared with market expectations of a gap of JPY 703.8 billion
The Eurozone Sentix Investor Confidence index came in at -25.2 in August from -26.4 in May vs. -24.7 expected. The
index resumed its recovery but failed to ease off recession fears.
The US Confer ence Board Employment Trends Index decreased in July 2022 to 117.63—down from a downwardly
revised 118.71 in June
10
The Daily
5 5-AUG-22 BUY LTTS AUG FUT 3576-3500 3,590.2 3,448.0 3,755.0 4.6 12-AUG-22
6 8-AUG-22 BUY IRCTC AUG FUT 650-640 659.0 634.0 685.0 3.9 15-AUG-22
7 8-AUG-22 BUY LT AUG FUT 1822-1784 1,834.9 1,757.0 1,914.0 4.3 15-AUG-22
8 29-JUL-22 BUY CYIENT 815.15-790 829.9 774.0 875.0 5.4 12-AUG-22
9 2-AUG-22 BUY PTC INDIA 84.40-81.50 82.8 79.8 91.2 10.2 16-AUG-22
10 2-AUG-22 BUY BOMBAY DYEING 102.15-99 100.6 97.0 109.0 8.3 16-AUG-22
11 3-AUG-22 BUY STAR 348.40-336 341.0 330.0 375.0 10.0 17-AUG-22
12 4-AUG-22 BUY CIPLA 1042.50-1013 1,029.6 995.0 1,104.0 7.2 18-AUG-22
13 5-AUG-22 BUY PURVANKARA PROJECTS 95-98.20 99.7 93.0 106.0 6.4 19-AUG-22
14 8-AUG-22 BUY GPPL 83.60-81 83.0 79.5 89.5 7.9 22-AUG-22
NO. RECO DT. RECO COMPANY NAME ENTRY CMP SL TARGET 1 TARGET 2 UPSIDE % VALID TILL
2 8-AUG-22 BUY TRIVENI TURBINE 192.7 192.6 177.0 210.0 230.0 19 8-NOV-22
12
The Daily
NO. RECO DT. RECO COMPANY NAME ENTRY CMP SL TARGET 1 TARGET 2 UPSIDE % VALID TILL
1 7-JUL-22 BUY GREAVES COTTON* 153.6 162.5 153.6 165.0 186.0 14 7-OCT-22
2 8-JUL-22 BUY FINOLEX CABLE 403.5 427.4 367.0 455.0 485.0 13 8-OCT-22
SAMAVARDHANA
3 19-JUL-22 BUY 125.8 128.6 125.8 134.6 149.0 16 19-OCT-22
MOTHERSON*
4 21-JUL-22 BUY BHARAT FORGE 682.9 712.5 629.0 760.0 790.0 11 21-OCT-22
5 25-JUL-22 BUY MPHASIS 2276.5 2391.2 2099.0 2542.0 2650.0 11 25-OCT-22
6 28-JUL-22 BUY AXIS BANK 719.0 745.6 675.0 764.0 790.0 6 28-OCT-22
7 28-JUL-22 BUY ALLCARGO 297.0 299.5 271.0 327.0 360.0 20 28-OCT-22
BHARAT
8 29-JUL-22 BUY 788.3 863.8 788.3 865.0 938.0 9 29-OCT-22
DYNAMICS*
9 29-JUL-22 BUY CENTURY TEXTILES 826.3 851.2 745.0 915.0 980.0 15 29-OCT-22
10 1-AUG-22 BUY CAPLIN POINT 808.0 813.4 743.0 890.0 980.0 20 1-NOV-22
11 1-AUG-22 BUY GSFC 161.3 163.4 147.0 182.0 197.0 21 1-NOV-22
12 1-AUG-22 BUY HEG LTD* 1180.8 1238.4 1180.8 1302.0 1431.0 16 1-NOV-22
13 2-AUG-22 BUY AVANTI FEEDS* 478.0 512.7 478.0 514.0 620.0 21 2-NOV-22
14 3-AUG-22 BUY IRCON 39.0 39.4 37.0 41.8 45.0 14 3-NOV-22
DEVYANI
15 3-AUG-22 BUY 180.7 188.7 180.7 193.0 205.0 9 3-NOV-22
INTERNATIONAL*
16 3-AUG-22 BUY INFOSYS 1559.4 1619.4 1440.0 1679.0 1800.0 11 3-NOV-22
17 8-AUG-22 BUY ASTRA MICRO 282.0 283.4 250.0 320.0 350.0 24 8-NOV-22
18 8-AUG-22 BUY EXIDE INDS 156.1 158.0 146.0 169.0 184.0 16 8-NOV-22
NIPPON LIFE ASSET
19 8-AUG-22 BUY 304.3 305.3 282.0 326.5 355.0 16 8-NOV-22
MANAGEMENT
13
The Daily
Indraprastha Gas 3193.9 481.2 154.0 73.1 32.7 11.7 Above Expectations
eClerx Services 617.8 99.5 27.1 8.1 4.4 -16.0 Below Expectations
AIA Engineering 1079.7 190.5 45.9 27.5 -1.2 -2.1 As per expectations
Talbros
153.0 11.9 11.9 19.5 3.3 -5.6 Below expectations
Automotive
VST Tillers &
236.0 10.1 21.9 -58.1 8.1 -54.5 Below expectations
Tractors
Operational
Granules India 1020 128 20.0 6.2 -1.0 15.0 performance lower
than estimates
In line with
Natco Pharma 885 320 115.6 327.2 48.2 -
expectations
Operational
Indoco Remedies 408 39 5.5 -2.8 -0.2 -4.7 performance lower
than estimates
In line with
JK Tyre 3643 37 39.7 -19.7 10.0 -7.5
expectations
In line with
Uno Minda 2555 139 59.5 801.0 5.8 -4.0
expectations
SeQuent Lower than
341 -14 6.5 - -11.0 -
Scientific estimates
*Standalone
LP= Loss to profit
The Daily
Disclaimer:
This report has been prepa red by HDFC Securi ties Ltd and is meant for sole use by the recipient and not for ci rcula tion. The
informa tion and opini ons contained herein ha ve been compiled or a rri ved a t, based upon information obtained in good fai th from
sources believed to be reliable. Such information has not been independentl y veri fied and no gua ranty, representation of warra nty,
express or implied, is made as to i ts accuracy, completeness or correctness . All such informa tion and opinions are subject to change
wi thout noti ce. This document is for informati on purposes onl y. Des cripti ons of any company or companies or thei r securities
mentioned herein a re not intended to be complete and this document is not, and should not be construed as an offer or
s ol icitation of a n offer, to buy or s ell a ny s ecurities or other fi nancial i nstruments.
This report is not di rected to, or intended for display, downloadi ng, printi ng, reproducing or for dis tributi on to or use by, any
person or enti ty who is a citi zen or resident or loca ted in any locali ty, s ta te, country or other jurisdi ction where such dis tribution,
publi cation, reproduction, a vailability or use would be contra ry to law or regulation or wha t would subject HSL or i ts a ffilia tes to
a ny registration or licensing requirement within such jurisdiction.
If this report is i nadvertentl y sent or has reached any person in such country, especiall y, Uni ted Sta tes of Ameri ca, the same should
be i gnored and brought to the attention of the sender. This document ma y not be reproduced, distributed or published in whole or
i n pa rt, directly or i ndirectly, for a ny purposes or i n a ny ma nner.
Foreign currencies denominated securi ties , wherever mentioned, a re subject to exchange ra te fl uctua tions , whi ch could ha ve an
adverse effect on thei r value or pri ce, or the i ncome deri ved from them. In addi tion, inves tors i n securi ties such as ADRs, the values
of whi ch are i nfluenced by foreign currencies effectively assume currency ri sk.
It should not be considered to be ta ken as an offer to sell or a soli ci ta tion to buy any securi ty. HSL ma y from time to time solici t
from, or perform broking, or other s ervices for, any company mentioned in this mail and/or i ts a ttachments.
HSL and i ts affiliated company(ies), thei r di rectors and employees ma y; (a) from ti me to ti me, ha ve a l ong or short posi tion i n, and
buy or sell the securi ties of the company(ies ) mentioned herein or (b) be engaged in any other transaction i nvol ving such securities
and ea rn brokerage or other compensation or act as a market ma ker in the financial ins truments of the company(ies) discussed
herei n or a ct as an advisor or lender/borrower to such company(ies) or ma y ha ve any other potential conflict of interes ts wi th
res pect to any recommendation and other related information and opinions.
HSL, i ts di rectors , anal ysts or employees do not take any responsibili ty, financial or otherwise, of the losses or the damages
sus tained due to the inves tments made or any a ction taken on basis of this report, including but not res tri cted to, fl uctua tion in the
pri ces of shares and bonds, changes in the currency ra tes, diminution i n the NAVs, reduction i n the dividend or i ncome, etc.
HSL and other group companies, i ts di rectors , associates , employees ma y ha ve va ri ous posi tions in any of the s tocks ,securi ties and
fi nancial ins truments dealt i n the report, or ma y make sell or purchase or other deals in these securi ties from time to ti me or ma y
dea l in other securities of the companies / organizations described i n this report.
HSL or i ts associates might ha ve managed or co-managed public offering of securi ties for the subject company or might ha ve been
ma ndated by the s ubject company for a ny other assignment in the past twelve months.
HSL or i ts associa tes might ha ve recei ved any compensation from the companies mentioned in the report during the peri od
preceding twel ve months from t da te of this report for servi ces in respect of managing or co-mana ging public offeri ngs , corpora te
fi nance, investment banking or merchant banking, brokera ge servi ces or other advisory servi ce in a merger or specifi c transa ction
i n the normal course of business.
HSL or i ts anal ys ts did not recei ve any compensa tion or other benefi ts from the companies mentioned in the report or thi rd pa rty in
connection wi th prepa ra tion of the research report. Accordingl y, nei ther HSL nor Research Anal ysts ha ve any material conflict of
interes t a t the time of publi ca tion of this report. Compensation of our Resea rch Anal ys ts is not based on any s pecifi c merchant
banking, investment banking or brokera ge servi ce transactions. HSL ma y ha ve issued other reports that are inconsistent wi th and
rea ch different conclusion from the information presented i n this report.
Resea rch enti ty has not been enga ged in ma rket making acti vi ty for the subject company. Resea rch anal yst has not served as an
officer, di rector or employee of the subject company. We ha ve not recei ved any compensation/benefi ts from the subject company
or thi rd party i n connection with the Research Report.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton
Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066
Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600
HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP:
11092018; IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser
Reg. No.: INA000011538; CIN - U67120MH2000PLC152193
Mutual Funds Investments a re subject to market risk. Please read the offer and s cheme related documents carefull y before
i nvesting.
15